Sumithra Srinath is a prominent inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel processes for drug preparation. With a total of five patents to his name, his work has had a considerable impact on the industry.

Latest Patents

Sumithra's latest patents include a process for the preparation of amorphous fluvastatin sodium. This invention relates to a novel method for producing the HMG-CoA reductase inhibitor, fluvastatin, specifically focusing on the amorphous form of fluvastatin sodium. Another notable patent is for the production of amorphous atorvastatin calcium, which outlines a novel process starting from a specific compound.

Career Highlights

Sumithra Srinath is currently employed at Biocon Limited, a leading biopharmaceutical company. His work at Biocon has allowed him to explore innovative solutions in drug formulation and development. His expertise in the pharmaceutical field has been recognized through his multiple patents.

Collaborations

Some of his notable coworkers include Sambasivam Ganesh and Tom Thomas Puthiaparampil. Their collaboration has contributed to the advancement of research and development within the company.

Conclusion

Sumithra Srinath's contributions to the pharmaceutical industry through his innovative patents demonstrate his commitment to advancing drug development. His work continues to influence the field and improve healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com